The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Effect of Stellate Ganglion Block on Meniere's Disease
Official Title: Effect of Stellate Ganglion Block on Meniere's Disease
Study ID: NCT01574313
Brief Summary: Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).
Detailed Description: Ten patients were randomly assigned to receive stellate ganglion block. These ten patients made up the experimental group. Another ten patients in the control group were assigned to receiving one dosage of oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate).
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
i Mei Medical Center Tainan, Taiwan, Taiwan, Tainan, , Taiwan
Name: Yung-Song Lin, M.D.
Affiliation: Chi Mei Medical Hospital
Role: PRINCIPAL_INVESTIGATOR